Skip to main content
Clinical Trials/ACTRN12617000079347
ACTRN12617000079347
Completed
Phase 4

A cluster randomised controlled trial to assess the impact of meningococcal B vaccine 4CMenB on nasopharyngeal carriage of N. Meningitidis in adolescents in South Australia

The University of Adelaide0 sites34,489 target enrollmentJanuary 16, 2017

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
The University of Adelaide
Enrollment
34489
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 16, 2017
End Date
December 31, 2018
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. South Australian secondary school students in years 10, 11, and 12 in 2017
  • 2\. Written parental consent for those under the age of 18
  • 3\. Written student consent\-assent for those under the age of 18 (or if 18 years old and older consent for themselves)
  • 4\. Available at school for at least the first pharyngeal swab

Exclusion Criteria

  • 1\. Previous recipient of 4CMenB vaccine (Bexsero)
  • 2\. Known pregnancy
  • 3\. Anaphylaxis following any component of the 4CMenB vaccine

Outcomes

Primary Outcomes

Not specified

Similar Trials